An ongoing FMT clinical trial (NCT05273255) being conducted at the University Hospital Zurich (Zurich, Switzerland), encompassing multiple solid tumors including PCa, aims to restore treatment sensitivity in recipients by altering their gut microbiota, thereby identifying specific microbial strains that could be utilized for future personalized therapies
Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, Zeegers MP, et al
Established brands strengthen their position through trusted raw materials, transparent documentation, practitioner-aligned formulations, and broad access across digital and specialty health channels, while traditional healthcare-affiliated brands participate selectively within antioxidant and amino-acid categories
A healthy diet supports skin regeneration, leading to a brighter complexion and even skin tone over time